Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines

Salim S. Virani, Julia M. Akeroyd, Sidney C. Smith, Mouaz Al-Mallah, Thomas M. Maddox, Pamela B. Morris, Laura A. Petersen, Christie M. Ballantyne, Scott M. Grundy, Neil J. Stone

Research output: Contribution to journalLetterpeer-review

20 Scopus citations
Original languageEnglish
Pages (from-to)712-714
Number of pages3
JournalJournal of the American College of Cardiology
Issue number5
StatePublished - Aug 6 2019

Cite this